Buy Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) Online

0 out of 5

  • DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease, Asthma
  • MANUFACTURER: GlaxoSmithKline
  • USAGE: Oral
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
  • Pharmaceuticals and Medical Devices Agency (PMDA)
  Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is prescribed as a continuous, maintenance therapy for individuals with asthma and chronic obstructive pulmonary disease (COPD).

$775.50
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist